Total raised
$8.6M
Last: Undisclosed 2024-01
Stage
Seed
Founded
2014
Headcount
21
HQ
Kefar Sava
Sector
Health Tech & Life Sciences
About
QuantalX™ introduces Delphi-MD™, a novel, FDA De Novo–authorized brain network function assessment device that leverages Direct Electrophysiological Imaging technology to map brain activity. Unlike conventional imaging, Delphi-MD™ captures functional responses in real time, providing clinicians with a powerful, non-invasive tool for accessible brain health insights across a wide range of care settings.
Funding history · 3 rounds · $8.6M total
2024-01
Undisclosed
Undisclosed
2022-12
Undisclosed
$400K
2021-04
Undisclosed
$8.2M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical Diagnostics
Technologies
Simulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProvidersLife Sciences
Business model
B2B
Highlights
1 PatentsVerified
Tags
brain-disorderdoctorshealthcarepersonalizationhealthcare-providersneurologyparkinsonchronic-patientstreatmentsdiagnosticsmedical-devicesneuro-stimulationalzheimers-diseasemonitoringsignal-processingcomputer-visionmental-healthneurovascularneurosurgeryepilepsynon-invasivechronic-painneurosciencepsychiatry